Understanding Clostridium difficile Colonization
- PMID: 29540433
- PMCID: PMC5967689
- DOI: 10.1128/CMR.00021-17
Understanding Clostridium difficile Colonization
Abstract
Clostridium difficile is the main causative agent of antibiotic-associated and health care-associated infective diarrhea. Recently, there has been growing interest in alternative sources of C. difficile other than patients with Clostridium difficile infection (CDI) and the hospital environment. Notably, the role of C. difficile-colonized patients as a possible source of transmission has received attention. In this review, we present a comprehensive overview of the current understanding of C. difficile colonization. Findings from gut microbiota studies yield more insights into determinants that are important for acquiring or resisting colonization and progression to CDI. In discussions on the prevalence of C. difficile colonization among populations and its associated risk factors, colonized patients at hospital admission merit more attention, as findings from the literature have pointed to their role in both health care-associated transmission of C. difficile and a higher risk of progression to CDI once admitted. C. difficile colonization among patients at admission may have clinical implications, although further research is needed to identify if interventions are beneficial for preventing transmission or overcoming progression to CDI.
Keywords: Clostridium difficile; health care-associated infections; intestinal colonization.
Copyright © 2018 American Society for Microbiology.
Figures









Similar articles
-
Acquisition of Clostridium difficile Colonization and Infection After Transfer From a Veterans Affairs Hospital to an Affiliated Long-Term Care Facility.Infect Control Hosp Epidemiol. 2017 Sep;38(9):1070-1076. doi: 10.1017/ice.2017.140. Epub 2017 Jul 11. Infect Control Hosp Epidemiol. 2017. PMID: 28693636
-
Colonization versus carriage of Clostridium difficile.Infect Dis Clin North Am. 2015 Mar;29(1):13-28. doi: 10.1016/j.idc.2014.11.001. Epub 2015 Jan 13. Infect Dis Clin North Am. 2015. PMID: 25595843 Review.
-
Insight into alteration of gut microbiota in Clostridium difficile infection and asymptomatic C. difficile colonization.Anaerobe. 2015 Aug;34:1-7. doi: 10.1016/j.anaerobe.2015.03.008. Epub 2015 Mar 26. Anaerobe. 2015. PMID: 25817005
-
Bloom and bust: intestinal microbiota dynamics in response to hospital exposures and Clostridium difficile colonization or infection.Microbiome. 2016 Mar 14;4:12. doi: 10.1186/s40168-016-0156-3. Microbiome. 2016. PMID: 26975510 Free PMC article.
-
Asymptomatic Clostridium difficile colonization: epidemiology and clinical implications.BMC Infect Dis. 2015 Nov 14;15:516. doi: 10.1186/s12879-015-1258-4. BMC Infect Dis. 2015. PMID: 26573915 Free PMC article. Review.
Cited by
-
Engineering probiotics to inhibit Clostridioides difficile infection by dynamic regulation of intestinal metabolism.Nat Commun. 2022 Jul 4;13(1):3834. doi: 10.1038/s41467-022-31334-z. Nat Commun. 2022. PMID: 35787625 Free PMC article.
-
Clostridioides difficile Prevalence in the United States: National Inpatient Sample, 2016 to 2018.Open Forum Infect Dis. 2021 Jul 30;8(9):ofab409. doi: 10.1093/ofid/ofab409. eCollection 2021 Sep. Open Forum Infect Dis. 2021. PMID: 34671694 Free PMC article.
-
Insights into the Role of Human Gut Microbiota in Clostridioides difficile Infection.Microorganisms. 2020 Jan 31;8(2):200. doi: 10.3390/microorganisms8020200. Microorganisms. 2020. PMID: 32023967 Free PMC article. Review.
-
Propensity-Matched Cost of Clostridioides difficile Infection Overdiagnosis.Open Forum Infect Dis. 2020 Dec 21;8(2):ofaa630. doi: 10.1093/ofid/ofaa630. eCollection 2021 Feb. Open Forum Infect Dis. 2020. PMID: 33575420 Free PMC article.
-
Human gut microbiota interactions shape the long-term growth dynamics and evolutionary adaptations of Clostridioides difficile.bioRxiv [Preprint]. 2024 Jul 17:2024.07.15.603560. doi: 10.1101/2024.07.15.603560. bioRxiv. 2024. Update in: Cell Host Microbe. 2025 Jan 8;33(1):42-58.e10. doi: 10.1016/j.chom.2024.12.001. PMID: 39071283 Free PMC article. Updated. Preprint.
References
-
- Walker AS, Eyre DW, Wyllie DH, Dingle KE, Harding RM, O'Connor L, Griffiths D, Vaughan A, Finney J, Wilcox MH, Crook DW, Peto TE. 2012. Characterisation of Clostridium difficile hospital ward-based transmission using extensive epidemiological data and molecular typing. PLoS Med 9:e1001172. doi: 10.1371/journal.pmed.1001172. - DOI - PMC - PubMed
-
- Curry SR, Muto CA, Schlackman JL, Pasculle AW, Shutt KA, Marsh JW, Harrison LH. 2013. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission. Clin Infect Dis 57:1094–1102. doi: 10.1093/cid/cit475. - DOI - PMC - PubMed
-
- Eyre DW, Cule ML, Wilson DJ, Griffiths D, Vaughan A, O'Connor L, Ip CL, Golubchik T, Batty EM, Finney JM, Wyllie DH, Didelot X, Piazza P, Bowden R, Dingle KE, Harding RM, Crook DW, Wilcox MH, Peto TE, Walker AS. 2013. Diverse sources of C. difficile infection identified on whole-genome sequencing. N Engl J Med 369:1195–1205. doi: 10.1056/NEJMoa1216064. - DOI - PMC - PubMed
-
- Debast SB, Bauer MP, Kuijper EJ, European Society of Clinical Microbiology and Infectious Diseases. 2014. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect 20(Suppl 2):S1–S26. doi: 10.1111/1469-0691.12418. - DOI - PubMed
-
- Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, Pepin J, Wilcox MH, Society for Healthcare Epidemiology of America, Infectious Diseases Society of America. 2010. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 31:431–455. doi: 10.1086/651706. - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources